PRESS RELEASE: Professor Clive Page appointed to Medical Advisory Board (11th November 2019)

Press Release: 11th November 2019

Sativa Group Plc
(“Sativa” or “the Company” or “the Group”)
Professor Clive Page, OBE, BSc, PhD, FSoB, FBPhS,
Professor of Pharmacology at King’s College London, appointed to Medical Advisory Board

Sativa Group Plc [NEX: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis Group, has appointed Clive Page, Professor of Pharmacology at King’s College London, to its Medical Advisory Board. Professor Page’s main research interests are in the pharmacology of inflammation and respiratory disease, and he has published over 300 scientific papers and book chapters.

He was awarded the Sandoz Prize from the British Pharmacological Society in 1988, The Tanabe Young Investigators Prize from the American College of Clinical Pharmacology in 1996 and the Society of Biology President’s Medal in 2012 for “Outstanding Contributions to the Life Sciences”. He is a Fellow of the Royal Society of Biology and an Honorary Fellow of the British Pharmacological Society. Professor Page was awarded an OBE for “Services to Pharmacology” in 2017.

Dr Nick Horniman, Director of Regulatory Affairs at Sativa, said: “Professor Page is an eminent research scientist and will add to Sativa’s experience, interest and understanding in cannabis based medical products.”

For further information please contact:

Henry Lees-Buckley
Chief Executive Officer
Sativa Group PLC
+44 (0) 20 7971 1255
[email protected]
www.sativagroup.co.uk

NEX Exchange Corporate Adviser
Corporate Finance
Stephen Keys / Max Gould
Cenkos Securities plc
+44 (0) 20 7397 8900

Equity Sales
Julian Morse
Cenkos Securities
+44 (0) 20 7397 8900

Financial PR and IR
Abchurch Communications
Julian Bosdet
+44 (0) 20 7459 4070
+44 (0) 7771 663 886
[email protected]
www.abchurch-group.com

Joseph Colliver
Chief Financial Officer
Sativa Group PLC
+44 (0) 20 7971 1255
[email protected]
www.sativagroup.co.uk

Notes to editors

Sativa Group Plc is the UK’s leading quoted CBD wellness and medicinal cannabis group with five
operating subsidiaries.

Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses.

Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfil its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and
respiratory conditions.

Share on facebook
Share on google
Share on twitter
Share on linkedin

Published on

Categories